The WISDOM study: a new approach to screening can and should be tested

Affiliations

¹ University of California, San Francisco, CA, 94158, USA. laura.esserman@ucsf.edu.
² Karolinska Institutet, Stockholm, Sweden.
³ University of California, San Francisco, CA, 94158, USA.
⁴ University of California, Los Angeles, CA, 90095, USA.
⁵ University of California, San Diego, CA, 92103, USA.
⁶ University of California, Davis, Sacramento, CA, 95817, USA.
⁷ University of California, Irvine, CA, 92868, USA.
⁸ Sanford Health, Sioux Falls, SD, 57104, USA.
⁹ University of Chicago, Chicago, IL, 60637, USA.
¹⁰ Louisiana State University, New Orleans, LA, 70112, USA.
¹¹ University of Alabama, Birmingham, AL, 35294, USA.
¹² Diagnostic Center for Women, Miami, FL, 33173, USA.

Editorial

Laura Esserman et al. Breast Cancer Res Treat. 2021 Oct.

. 2021 Oct;189(3):593-598.

doi: 10.1007/s10549-021-06346-w. Epub 2021 Sep 16.

¹ University of California, San Francisco, CA, 94158, USA. laura.esserman@ucsf.edu.
² Karolinska Institutet, Stockholm, Sweden.
³ University of California, San Francisco, CA, 94158, USA.
⁴ University of California, Los Angeles, CA, 90095, USA.
⁵ University of California, San Diego, CA, 92103, USA.
⁶ University of California, Davis, Sacramento, CA, 95817, USA.
⁷ University of California, Irvine, CA, 92868, USA.
⁸ Sanford Health, Sioux Falls, SD, 57104, USA.
⁹ University of Chicago, Chicago, IL, 60637, USA.
¹⁰ Louisiana State University, New Orleans, LA, 70112, USA.
¹¹ University of Alabama, Birmingham, AL, 35294, USA.
¹² Diagnostic Center for Women, Miami, FL, 33173, USA.

No abstract available

References

1. Shieh Y, Eklund M, Madlensky L et al (2017) Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial. J National Cancer Inst 109(5):djw290. https://doi.org/10.1093/jnci/djw290 - DOI
1. Esserman LJ (2017) The WISDOM Study: breaking the deadlock in the breast cancer screening debate. NPJ Breast Cancer 3(1):34. https://doi.org/10.1038/s41523-017-0035-5 - DOI - PubMed - PMC
1. Eklund M, Broglio K, Yau C, Connor JT, Fiscalini AS, Esserman LJ (2018) The WISDOM personalized breast cancer screening trial: simulation study to assess potential bias and analytic approaches. JNCI Cancer Spectr 2(4):279. https://doi.org/10.1093/jncics/pky067 - DOI
1. Consortium IST, Yee D, DeMichele AM et al (2020) Association of event-free and distant recurrence-free survival with individual-level pathologic complete response in neoadjuvant treatment of stages 2 and 3 breast cancer. JAMA Oncol 6(9):1355–1362. https://doi.org/10.1001/jamaoncol.2020.2535 - DOI
1. Rugo HS, Olopade OI, DeMichele A et al (2016) Adaptive randomization of veliparib-carboplatin treatment in breast cancer. N Engl J Med 375(1):23–34. https://doi.org/10.1056/nejmoa1513749 - DOI - PubMed - PMC